Actuate Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACTU and other ETFs, options, and stocks.About ACTU
Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases.
CEODaniel M. Schmitt
CEODaniel M. Schmitt
Employees10
Employees10
HeadquartersFort Worth, Texas
HeadquartersFort Worth, Texas
Founded2015
Founded2015
Employees10
Employees10
ACTU Key Statistics
Market cap174.56M
Market cap174.56M
Price-Earnings ratio-6.22
Price-Earnings ratio-6.22
Dividend yield—
Dividend yield—
Average volume86.86K
Average volume86.86K
High today$7.64
High today$7.64
Low today$7.30
Low today$7.30
Open price$7.46
Open price$7.46
Volume104.14K
Volume104.14K
52 Week high$11.99
52 Week high$11.99
52 Week low$5.47
52 Week low$5.47
Stock Snapshot
The current Actuate Therapeutics(ACTU) stock price is $7.52, with a market capitalization of 174.56M. The stock trades at a price-to-earnings (P/E) ratio of -6.22.
On 2025-12-13, Actuate Therapeutics(ACTU) stock traded between a low of $7.30 and a high of $7.64. Shares are currently priced at $7.52, which is +3.0% above the low and -1.6% below the high.
The Actuate Therapeutics(ACTU)'s current trading volume is 104.14K, compared to an average daily volume of 86.86K.
During the past year, Actuate Therapeutics(ACTU) stock moved between $5.47 at its lowest and $11.99 at its peak.
During the past year, Actuate Therapeutics(ACTU) stock moved between $5.47 at its lowest and $11.99 at its peak.
People also own
Based on the portfolios of people who own ACTU. This list is generated using Robinhood data, and it’s not a recommendation.